TMEM37 and AL amyloidosis: Moreover, PR1 cross-presenting myeloma cells were found to be susceptible to both CTLs and anti-PR1/HLA-A2-mediated killing, and although data were still preliminary, they let PR1 emerge as a promising new prospect in multiple myeloma [60].